glp 1 glp 2 GLP-1 receptor agonists are increasingly used to treat type diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Positive impact of GIP, GLP-1

Summary Keywords GLP 1, nausea & vomiting, obesity, semaglutide, side effect, tirzepatide Citation Alhazmi A and le Roux CW (2026) Do no harm: managing nausea and vomiting in GLP-1 based obesity therapies

Unlike glutathione tablets and capsules which may cause some gastric discomfort for those with a sensitive stomach, liposomal glutathione is generally free from side effects

Aliment Pharmacol Ther 37:234242 Petit JM, Cercueil JP, Loffroy R et al (2017) Effect of Liraglutide therapy on liver fat content in patients with inadequately controlled type 2 diabetes: the lira-NAFLD study

Auch diese Wirkung ist nicht eindeutig belegt